Planning to Survive Survivorship care plans can prepare cancer patients to get the best medical care and maintain their quality of life following treatment. by Carly Flumer Survivor Profile Sharing Her Strength Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer. by Lindsey Konkel What It’s Like to Get a “C” in Graduate School I was afraid that my thyroid cancer diagnosis would derail my graduate school plans. Instead, it helped shape my career path. by Carly Flumer “Congrats! You Have the ‘Good’ Cancer” Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer. by Carly Flumer Advocacy Spotlight: A Mission to Bring Awareness Minister and thyroid cancer survivor Thurselle C. Williams speaks at conferences and events about cancer awareness and, ultimately, healing following her 2016 diagnosis. by Erin L. Boyle Forward Look Thyroid Tumor Gets New Name Panel reclassifies a type of thyroid tumor, says it's not cancer. by Yasmine Iqbal Survivor Profile Stop the Silence Cancer survivor Cherry Sloan-Medrano works to encourage a conversation about cancer among Asians in the U.S. by Jenny Song Deciphering New Rates of Thyroid Cancer Experts are divided on whether the increase is due to more cancer or more diagnoses. by Melissa Weber Q&A Facing the Critics Roger Ebert finds peace with his appearance following disfiguring cancer surgery. by Ronni Gordon Cancer Talk Cancer Centers Cope With COVID-19 Surge Doctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge. by Ashley P. Taylor Why Do African Americans Have Increased Breast Cancer Mortality? Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates. by Marci A. Landsmann Liquid Biopsies May Ease Enrollment in Clinical Trials A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials. by Emma Yasinski What Is Tumor Mutational Burden? The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types. by Anna Azvolinsky More Posts